In the 2016 & 2021 World Health Organization (WHO) classification of tumors of the CNS, GS was classified as a subtype of isocitrate dehydrogenase (IDH)-wildtype GBM (2) and a variant of GBM (3, 4) respectively. The gene discussed is IDH3A; the disease is glioblastoma.